Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111101-111150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03179904
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
PHASE2Active, not recruiting
19 participants
Started: Aug 3, 2017 · Completed: Dec 31, 2025
5 conditions1 sponsor3 locations
NCT02935517
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Aug 3, 2017 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations
NCT03261089
Multimodal Outcome CHAracterization in Comatose Cardiac Arrest Patients Registry and Tissue Repository
N/ARecruiting
600 participants
Started: Aug 2, 2017 · Completed: Aug 31, 2027
1 condition10 sponsors1 location
NCT02883062
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
PHASE2Active, not recruiting
67 participants
Started: Aug 2, 2017 · Completed: Sep 11, 2026
4 conditions1 sponsor14 locations
NCT03217747
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
PHASE1/PHASE2Active, not recruiting
173 participants
Started: Aug 2, 2017 · Completed: Apr 30, 2026
10 conditions2 sponsors1 location
NCT03199469
A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)
PHASE2/PHASE3Active, not recruiting
27 participants
Started: Aug 2, 2017 · Completed: Mar 31, 2030
1 condition1 sponsor6 locations
NCT03578003
Morning Bright Light to Improve Sleep Quality in Veterans
NARecruiting
200 participants
Started: Aug 2, 2017 · Completed: Aug 2, 2026
2 conditions2 sponsors1 location
NCT03237702
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics
NARecruiting
2,000 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2025
1 condition9 sponsors1 location
NCT04384913
Kinematic Versus Mechanical Alignment in Total Knee Replacement
N/AActive, not recruiting
130 participants
Started: Aug 1, 2017 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT03946410
Danish Cardiovascular Screening Trial II
NAActive, not recruiting
38,000 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2027
2 conditions2 sponsors4 locations
NCT03161067
Investigation on the Bidirectional Cortical Neuroprosthetic System
NARecruiting
5 participants
Started: Aug 1, 2017 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT04741906
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
N/ARecruiting
225 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT04708535
Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance
N/AEnrolling by invitation
50 participants
Started: Aug 1, 2017 · Completed: Aug 31, 2025
4 conditions2 sponsors1 location
NCT03162432
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
PHASE3Active, not recruiting
50 participants
Started: Aug 1, 2017 · Completed: Dec 1, 2023
3 conditions1 sponsor1 location
NCT03377647
An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation
NAActive, not recruiting
300 participants
Started: Aug 1, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT07147452
Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
N/AActive, not recruiting
44 participants
Started: Aug 1, 2017 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT03505983
Criteria for Advanced Prosthetic Foot Prescription
NAActive, not recruiting
91 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT04737525
Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement
NAActive, not recruiting
50 participants
Started: Aug 1, 2017 · Completed: Feb 10, 2031
1 condition2 sponsors1 location
NCT02704858
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PHASE1/PHASE2Recruiting
49 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT03223766
Evaluation of Proton Therapy in Pediatric Cancer Patients
N/AActive, not recruiting
1,000 participants
Started: Aug 1, 2017 · Completed: Jul 31, 2037
1 condition1 sponsor1 location
NCT03313011
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
N/ARecruiting
47 participants
Started: Aug 1, 2017 · Completed: Jul 31, 2027
4 conditions1 sponsor1 location
NCT03215862
Lactated Ringer's Solution to Prevent Post-ERCP Pancreatitis
NANot yet recruiting
242 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2018
1 condition1 sponsor0 locations
NCT03408106
Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients
N/AActive, not recruiting
20 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2030
1 condition1 sponsor2 locations
NCT03160131
Rehabilitation of Visual Function After Brain Injury
NARecruiting
56 participants
Started: Aug 1, 2017 · Completed: Jul 31, 2027
4 conditions3 sponsors1 location
NCT03031912
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
PHASE2Active, not recruiting
250 participants
Started: Aug 1, 2017 · Completed: Feb 28, 2025
1 condition6 sponsors1 location
NCT03249519
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
NARecruiting
999 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT03111459
Repair of Thoracoabdominal Aortic Aneurysms
NARecruiting
15 participants
Started: Aug 1, 2017 · Completed: May 31, 2029
1 condition2 sponsors1 location
NCT03199729
Aging and Mixed Perturbation Training to Reduce Falls in Locomotion
NAActive, not recruiting
600 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03167814
Prevention of Chyle-leak After Major Pancreatic Surgery
NARecruiting
96 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03234179
A Prognosis and Predicting Genetic Study of Lung Cancer
N/ANot yet recruiting
500 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2037
2 conditions1 sponsor0 locations
NCT03222531
Expanding the Pool in Orthotopic Heart Transplantation
PHASE2Active, not recruiting
20 participants
Started: Aug 1, 2017 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT03043716
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP
N/AActive, not recruiting
14,147 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
3 conditions2 sponsors6 locations
NCT03238755
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study
N/AActive, not recruiting
129 participants
Started: Jul 31, 2017 · Completed: Apr 23, 2026
1 condition3 sponsors4 locations
NCT03221543
Resting Metabolic Rate Testing in Bariatric Surgery Patients
NAEnrolling by invitation
50 participants
Started: Jul 31, 2017 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT03206099
NIAID Centralized Sequencing Protocol
N/ARecruiting
20,000 participants
Started: Jul 31, 2017 · Completed: Dec 31, 2029
4 conditions2 sponsors2 locations
NCT03155620
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
PHASE2Active, not recruiting
1,376 participants
Started: Jul 31, 2017 · Completed: May 9, 2026
45 conditions1 sponsor172 locations
NCT04312672
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
N/AActive, not recruiting
42 participants
Started: Jul 31, 2017 · Completed: Nov 18, 2026
1 condition1 sponsor5 locations
NCT03104491
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
PHASE1/PHASE2Recruiting
44 participants
Started: Jul 31, 2017 · Completed: May 31, 2027
1 condition1 sponsor7 locations
NCT03247088
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
PHASE1/PHASE2Active, not recruiting
74 participants
Started: Jul 30, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03231332
Effects of H.Pylori Eradication on Microbiome
PHASE4Enrolling by invitation
900 participants
Started: Jul 29, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03274687
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
PHASE3Active, not recruiting
296 participants
Started: Jul 28, 2017 · Completed: Aug 3, 2026
4 conditions2 sponsors241 locations
NCT03136887
JOURNEY II XR Safety and Effectiveness PMCF
N/AActive, not recruiting
176 participants
Started: Jul 28, 2017 · Completed: Apr 30, 2029
6 conditions1 sponsor14 locations
NCT03269526
BATs Treatment for Pancreatic Cancer, Phase Ib/II
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jul 28, 2017 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT06331377
Clinical and Molecular Characteristics of Histiocytic Disorders
N/ARecruiting
500 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT03449264
Development of Clinical and Biological Database
NARecruiting
4,000 participants
Started: Jul 27, 2017 · Completed: Nov 30, 2037
4 conditions1 sponsor1 location
NCT03190928
Clonal Evolution in Follicular Lymphoma
N/ARecruiting
200 participants
Started: Jul 27, 2017 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT03024008
Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 27, 2017 · Completed: Jun 30, 2027
1 condition1 sponsor6 locations
NCT03181100
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
PHASE2Active, not recruiting
50 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2027
7 conditions2 sponsors1 location
NCT03201861
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
PHASE3Recruiting
762 participants
Started: Jul 27, 2017 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT03244306
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma
PHASE1Active, not recruiting
4 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2035
1 condition1 sponsor1 location